AprilBio Co Ltd
KOSDAQ:397030
Income Statement
Earnings Waterfall
AprilBio Co Ltd
Income Statement
AprilBio Co Ltd
| Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||||||
| Interest Expense |
810
|
818
|
93
|
30
|
31
|
931
|
713
|
1 110
|
1 525
|
1 420
|
1 237
|
1 040
|
825
|
|
| Revenue |
23 396
N/A
|
23 396
N/A
|
23 596
+1%
|
200
-99%
|
200
N/A
|
0
N/A
|
0
N/A
|
20 712
N/A
|
20 712
N/A
|
27 514
+33%
|
29 686
+8%
|
8 974
-70%
|
8 974
N/A
|
|
| Gross Profit | ||||||||||||||
| Cost of Revenue |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Gross Profit |
23 396
N/A
|
23 396
N/A
|
23 596
+1%
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
| Operating Income | ||||||||||||||
| Operating Expenses |
(13 169)
|
(15 411)
|
(15 688)
|
(11 674)
|
(12 230)
|
(13 388)
|
(5 171)
|
(7 714)
|
(10 145)
|
(10 645)
|
(10 407)
|
(10 521)
|
(10 711)
|
|
| Selling, General & Administrative |
(3 809)
|
(4 667)
|
(6 085)
|
(4 156)
|
(4 418)
|
(4 675)
|
(2 766)
|
(4 768)
|
(6 557)
|
(6 734)
|
(6 808)
|
(6 192)
|
(4 960)
|
|
| Research & Development |
(8 951)
|
(10 189)
|
(9 023)
|
(6 925)
|
(7 201)
|
(8 038)
|
(2 043)
|
(2 403)
|
(2 874)
|
(3 205)
|
(2 902)
|
(3 636)
|
(4 937)
|
|
| Depreciation & Amortization |
(409)
|
(554)
|
(581)
|
(593)
|
(610)
|
(674)
|
(362)
|
(542)
|
(714)
|
(706)
|
(696)
|
(693)
|
(692)
|
|
| Other Operating Expenses |
0
|
0
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(122)
|
|
| Operating Income |
10 227
N/A
|
7 985
-22%
|
7 908
-1%
|
(11 474)
N/A
|
(12 030)
-5%
|
(13 388)
-11%
|
(5 171)
+61%
|
12 998
N/A
|
10 567
-19%
|
16 869
+60%
|
19 279
+14%
|
(1 547)
N/A
|
(1 737)
-12%
|
|
| Pre-Tax Income | ||||||||||||||
| Interest Income Expense |
(3 896)
|
(2 923)
|
2 440
|
2 365
|
2 695
|
(712)
|
(2 687)
|
(2 272)
|
(2 961)
|
3 265
|
3 480
|
2 630
|
829
|
|
| Non-Reccuring Items |
4
|
4
|
4
|
10
|
7
|
3
|
0
|
0
|
0
|
(123)
|
(123)
|
(122)
|
0
|
|
| Gain/Loss on Disposition of Assets |
0
|
0
|
0
|
(0)
|
0
|
(26)
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
|
| Total Other Income |
79
|
79
|
79
|
140
|
61
|
(6)
|
(10)
|
(18)
|
(16)
|
(6)
|
(7)
|
(1)
|
31
|
|
| Pre-Tax Income |
6 413
N/A
|
5 145
-20%
|
10 430
+103%
|
(8 959)
N/A
|
(9 267)
-3%
|
(14 130)
-52%
|
(7 868)
+44%
|
10 709
N/A
|
7 590
-29%
|
20 005
+164%
|
22 629
+13%
|
959
-96%
|
(878)
N/A
|
|
| Net Income | ||||||||||||||
| Tax Provision |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Income from Continuing Operations |
6 413
|
5 145
|
10 430
|
(8 959)
|
(9 267)
|
(14 130)
|
(7 868)
|
10 709
|
7 590
|
20 005
|
22 629
|
959
|
(878)
|
|
| Net Income (Common) |
6 413
N/A
|
5 145
-20%
|
10 430
+103%
|
(8 959)
N/A
|
(9 267)
-3%
|
(14 130)
-52%
|
(7 868)
+44%
|
10 709
N/A
|
7 590
-29%
|
20 005
+164%
|
22 629
+13%
|
959
-96%
|
(878)
N/A
|
|
| EPS (Diluted) |
609.95
N/A
|
489.35
-20%
|
1 022.29
+109%
|
-457.78
N/A
|
-875.29
-91%
|
-661.64
+24%
|
-364
+45%
|
493.25
N/A
|
346.69
-30%
|
913.04
+163%
|
1 007.37
+10%
|
42.62
-96%
|
-38.86
N/A
|
|